BrightPath Biotherapeutics Co., Ltd. Stock price
Equities
4594
JP3274140007
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
67 JPY | +4.69% | +1.52% | -22.99% |
Sales 2017 | 529M 3.49M | Sales 2018 | 354M 2.34M | Capitalization | 33.68B 222M |
---|---|---|---|---|---|
Net income 2017 | -1.11B -7.35M | Net income 2018 | -1.58B -10.42M | EV / Sales 2017 | 34.8 x |
Net cash position 2017 | 4.95B 32.69M | Net cash position 2018 | 6.53B 43.12M | EV / Sales 2018 | 76.7 x |
P/E ratio 2017 |
-19.2
x | P/E ratio 2018 |
-19.5
x | Employees | 42 |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 95.5% |
1 day | +4.69% | ||
1 week | +1.52% | ||
Current month | -16.25% | ||
1 month | -16.25% | ||
3 months | -22.99% | ||
6 months | -50.74% | ||
Current year | -22.99% |
Managers | Title | Age | Since |
---|---|---|---|
Kenichi Nagai
CEO | Chief Executive Officer | 53 | 08-12-31 |
Director/Board Member | 55 | 16-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 15-05-31 | |
Akira Yamada
BRD | Director/Board Member | 67 | 03-04-30 |
Kenichi Nagai
CEO | Chief Executive Officer | 53 | 08-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-29 | 67 | +4.69% | 388 900 |
24-03-28 | 64 | 0.00% | 608,800 |
24-03-27 | 64 | -1.54% | 718,900 |
24-03-26 | 65 | -1.52% | 847,900 |
24-03-25 | 66 | 0.00% | 473,800 |
Delayed Quote Japan Exchange, March 29, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-22.99% | 28.08M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |